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We present here a case of extrathyroid CASTLE (the third case reported in the English literature) treated with
excision and neck dissection without radiotherapy. Also, we reviewed the literature and analyzed the therapeutic
results of each treatment modality for CASTLE. A 27-year-old male had initially presented with a painless, right neck
mass for 2 months. Computed tomography of the neck showed a 3.8 × 3.2 × 3.8 cm heterogeneously enhancing
mass at right level IIa, and no definite thyroid lesion was found. An excisional biopsy was done and the pathologic
diagnosis was CASTLE. Then we performed a right modified radical neck dissection and right thyroid lobectomy.
After three years, no evidence of tumor recurrence was noted. Total excision followed by neck dissection could be
a sufficient surgical treatment option for CASTLE. Postoperative radiotherapy might be an alternative treatment
option for neck dissection in patients with positive nodal status.
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Carcinoma showing thymus-like differentiation (CASTLE)
is a rare tumor of the thyroid gland or adjacent soft tissues
of the neck [1]. First described as an intrathyroid epithelial
thymoma by Miyauchi et al. in 1985 [2], these lesions
were later designated CASTLE by Chan and Rosai, who
proposed an origin from ectopic thymus, or from thymo-
pharyngeal duct or branchial pouch remnants in the thy-
roid gland and neck [3]. The majority of tumors occur in
the thyroid gland, usually in the lower portion, and they
rarely arise in the extrathyroidal soft tissue of the neck.
The histopathology of CASTLE is characterized by an
expansive growth pattern, thick fibrous bands dividing
the tumor nests, the presence of lymphocytes and rare or
infrequent mitoses [4]. Generally, the treatment is surgical
excision with or without radiotherapy, but the definitive* Correspondence: djlee@hallym.or.kr
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unless otherwise stated.treatment remains uncertain, due to the rarity of the
disease.
According to reports in the English-language literature,
less than 30 cases of CASTLE tumors have been reported,
and only two cases were extrathyroid tumors [5]. One case
was reported by Ahuja in 1998, in which a female patient
with a lateral neck CASTLE was treated by resection and
radiotherapy without recurrence [6], and the other case
was described by Luo, in which a lateral neck CASTLE
was treated without locoregional recurrence by surgical
excision and radiotherapy [5].
Here, we report a case of extrathyroid CASTLE, which
was diagnosed by excisional biopsy, successfully treated
by unilateral neck dissection with ipsilateral thyroid lob-
ectomy, without concomitant radiotherapy.Case presentation
A 27-year-old male was admitted to our department with
a palpable neck mass that appeared two months ago. He
denied any other symptoms. His past medical history was
significant only for left chronic otitis media with mild
hearing disturbance, and both chronic sinusitis, which wasd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ago. On physical examination, the 3-cm-sized mass was
hard and fixed, locating at right level IIa. No obvious
lesion was found in the oral cavity, nasopharynx, oro-
pharynx or hypopharynx. Laboratory tests showed a white
blood cell count of 7,480 mm3 with 64.2% neutrophils,
and the serum concentrations of thyroxine, thyroid-
stimulating hormone and thyroglobulin were all normal.
Neck ultrasonography revealed multiple tiny cystic-
hypoechoic nodules in both thyroid glands, and a 3.8 ×
3.2 × 3.8 cm mass with heterogeneous echogenicity in the
right submandibular area. Computed tomography (CT)
with enhancement of the neck showed the same-sized het-
erogeneously enhancing mass at right level IIa (Figure 1).
Ultrasonogram guided fine-needle aspiration (FNA) bio-
psy of the mass was performed and only atypical plump
spindle cells were found. We performed a second FNA
biopsy after two weeks. The cytologic examination showed
plump epitheloid and spindle cells with infiltration of
lymphoid cells and eosinophils. An immunohistochemical
stain of the cytology showed that the tumor was positive
for keratin, high-molecular keratin, vimentin and galectin-
3, and focally positive for Factor VIII.
To make a definite diagnosis, we scheduled an exci-
sional biopsy of the mass. Under general anesthesia, a skin
incision over the mass and subsequent dissection of the
platysma muscle was done, and the tumor appeared just
inferior to the right submandibular gland. The tumor was
well encapsulated with several lymph nodes around it.
Excision of the mass along with six right level IIa lymph
nodes was performed. No other specific intraoperativeFigure 1 Computed tomography (CT) findings. CT with
enhancement showing heterogeneously enhancing mass at right
level II (arrows, tumor margin).findings were noticed and the frozen biopsy revealed
not much and no malignant tissue was found. One week
after, a final report of the permanent pathology was made
and the diagnosis was carcinoma showing a thymus-like
element. Histological examination of the mass showed
an infiltrative neoplasm composed of epithelial cell nests
separated by thick fibrous septa, with an accompanying
infiltrate of small lymphocytes and eosinophils (Figure 2).
Immunohistochemical stains of the mass for CD5, cyto-
keratin and P63 were positive, and negative for thyroid
transcription factor-1. The six lymph nodes had no tumor
present.
The patient refused radiotherapy, but agreed on
complete surgical eradication of the disease. Because of
the patient’s young age, we scheduled a right modified
radical neck dissection, along with ipsilateral thyroid lob-
ectomy to rule out a thyroid origin. Preoperative positron
emission tomography-computed tomography (PET-CT)
showed no metabolic evidence of malignancy, and an
ultrasonogram guided thyroid nodule FNA biopsy result
was non diagnostic. Finally, two months after the first
operation, a right modified radical neck dissection (levels I
to V) and ipsilateral thyroid lobectomy were performed. A
thyroid lobectomy was added to our surgery because most
CASTLE tumors are intrathyroid, and also to give a de-
finite diagnosis of the patient’s thyroid nodule. On in-
traoperative inspection and palpation of the thyroid, no
noticeable intrathyroid mass was found. The surgery was
finished without difficulty, and no other specific intraoper-
ative findings were noted. The pathologic report of the
right thyroid lobe was multinodular goiter and no definite
neoplastic lesion was identified. All the lymph nodes in right
levels I to V were non-neoplastic (reactive hyperplasia). The
patient was discharged on the ninth hospital day without
any postoperative complications, and was then regularly
followed up in the outpatient department. After six
months, a follow up PET-CT was taken and no metabolic
evidence of regional tumor recurrence or metastasis was
reported. At the most recent follow-up, i.e. three years
after the second operation, no evidence of tumor recur-
rence was present.
Discussion
CASTLE is a rare malignant neoplasm that histologically
resembles thymic carcinoma, and arises in the thyroid
gland or adjacent soft tissue of the neck. During em-
bryological development, primordial thymic tissue derived
from the third and fourth branchial pouches migrates
through the neck and into the mediastinum [7]. Persist-
ence of thymic remnants along this path can manifest as
ectopic thymic tissue [3]. CASTLE is postulated to arise
from either this ectopic tissue, from remnants of the thy-
mopharyngeal duct or from ultimobranchial body rem-
nants within the thyroid gland [3,8]. According to previous
Figure 2 Histopathological features of the tumor. (A) Tumor cell nests separated by fibrous bands (white arrow, hematoxylin and eosin stain;
original magnification × 40), (B) with accompanying lymphocyte (black arrow) and eosinophil (white arrow) infiltration (hematoxylin and eosin
stain; original magnification × 400).
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gland, especially the lower portion. From a review of litera-
ture, only three CASTLE tumors have been reported in
the lateral neck including this case [5,6]. Table 1 sum-
marizes the clinical characteristics, treatments and cli-
nical outcomes of the three patients with extrathyroidal
CASTLE.
An FNA biopsy seems to offer limited diagnostic value
for CASTLE. Youens et al. identified 27 cases of reported
CASTLE that mentioned an FNA biopsy [1]. Reported
cytological differential diagnoses vary, with the majority
of cases being identified as a malignant tumor, without
further definite classification. One reported case was iden-
tified as suggestive of spindle cell neoplasm, one was iden-
tified as a papillary carcinoma, and one was correctly
identified as CASTLE preoperatively. In 23 of 27 reported
cases, CASTLE was correctly identified as malignant, and
in one case, the FNA was negative. In our case, the FNA
biopsy showed epitheloid and spindle cells with infiltration
of lymphoid cells and eosinophils. CASTLE can beTable 1 Clinical characteristics, treatments, and outcomes of
Cases Ahuja et al. [6] Luo e
Age (years)/sex 67/female 47/ma
Tumor size 9 × 7 × 5 cm 5 × 5 ×
Location in neck Left Left
Cystic changes Not described Partial
Inflammatory cell infiltration Numerous lymphocytes Lymph




LN pathology LN metastasis (1/22) No tum




Outcome No recurrence No rec
LN, lymph node.definitively diagnosed only by experienced pathologists
through histologic examination. CASTLE produces a lob-
ulated and expansive growth pattern with fibrous septa
dividing the tumor, large vesicular nuclei with prominent
nucleoli, a low mitotic count, and may be associated with
lymphoplasmacytic infiltration [2,3,9], as seen in our pa-
tient (Figure 2). Small focal squamous differentiation in
whorled clusters, resembling Hassall’s corpuscles, may also
be seen [5].
In their study, Luo et al. found 26 reported cases of
CASTLE, 25 intrathyroid cases, one extrathyroid case, and
added one extrathyroid CASTLE, which they reported
[5]. The 25 cases of intrathyroid CASTLE were treated
with surgical excision (thyroidectomy, neck dissection,
etc.) with or without radiotherapy. A review of all reported
cases showed that 16 of 27 patients had no evidence of
recurrence at follow-up after treatment, and 10 of 27 had
a recurrence. There was one case of recurrence with initial
misdiagnosis. Four of the ten recurrent cases showed no
evidence of recurrence after salvage treatment; one patientpatients with extrathyroidal origin CASTLE
t al. [5] This case
le 27/male
4 cm 3.8 × 3.8 × 3.2 cm
Right
Partial
ocytes Abundant lymphocytes and eosinophils
l small LNs surrounding
ass




Mass excision, right modified radical neck
dissection (levels I–V)
urrence No recurrence over 3-year period
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disease with local recurrence or distant metastasis to the
lung or liver. Most of the recurrences were noted in
patients with invasion of the neck lymph nodes or sur-
rounding tissue. Two cases of extrathyroid CASTLE were
treated by resection and radiotherapy, and neither showed
locoregional recurrence.
There is no consensus on the management of CASTLE,
due to the rarity of the disease, but complete surgical ex-
cision with or without radiotherapy seems necessary to
improve the long-term survival rate and reduce the locor-
egional recurrence rate. Table 2 summarizes the treatment
modalities and therapeutic results of CASTLE, from a re-
view of the literature. We added six new cases from the
recent literature for which we could find the treatment
modalities and therapeutic results [10-13]. In cases with a
tumor excision only, tumor recurrence occurred in six
cases and there was no evidence of disease (NED) for
seven cases. But for cases who had either radiation therapy
or neck dissection after complete excision, recurrence oc-
curred only for three cases and there was NED for nine
cases. On the basis of these case reviews, we noticed that
excision with either radiation or neck dissection showed
better results than excision only. Additionally, if there is a
positive node in the neck dissection specimen, postopera-
tive radiation might be helpful as this adjuvant therapy re-
duced the recurrence rate from 100% to 57% (1/1 to 4/7).
In contrast, if there is no metastatic node in the neck
dissection specimen, postoperative radiation therapy does
not seem necessary as recurrence has never occurred in
node negative cases after neck dissection.
In summary, the most successful treatment from a re-
view of the literature was complete surgical excision
followed by neck dissection with or without postoperative
adjuvant radiation therapy depending on nodal state. InTable 2 Treatment modalities and therapeutic results of
reported CASTLEs [5,6,10-13]
Treatment modality Recurrence NED
Excision only 6 7
Excision + RT 2 4
Excision + RT* 0 1
Excision + ND N (+) 1 N (+) 0
N (-) 0 N (-) 3
Excision + ND* N (-) 0 N (-) 1
Excision + ND + RT N (+) 4 N (+) 2
N (-) 0 N (-) 2
Excision + ND + RT* N (+) 0 N (+) 1
Total 13 21
*The three cases of extra-thyroid CASTLE.
N (+), node positive in neck dissection specimen; N (-), node negative in
neck dissection specimen; ND, neck dissection; NED, no evidence of disease;
RT, radiation therapy.our case, complete excision by neck dissection without
radiotherapy achieved a positive result as there was no
metastatic node in the neck specimen. Interestingly, all
extrathyroid CASTLE cases (‘*’ in Table 2) showed NED.
All three cases were treated by excision with either ra-
diotherapy or neck dissection. The reason for the better
prognosis compared with intrathyroid CASTLE might be
the isolated origin site of extrathyroid CASTLE, and the
higher feasibility of complete excision than intrathyroid
CASTLE, which extends to the mediastinum. Extrathyroid
CASTLE is difficult to diagnose, and there is no reported
suitable treatment. In this case, the patient was diagnosed
by excisional biopsy, and a subsequent unilateral neck
dissection with ipsilateral thyroid lobectomy achieved a
disease-free state. However, a longer follow-up in a larger
series of patients is needed to support our result.Conclusions
We present a case of extrathyroid CASTLE, which was
successfully treated by excision plus unilateral neck dissec-
tion. From a review of the literature, the most successful
treatment of CASTLE is complete surgical excision fol-
lowed by neck dissection with or without postoperative
adjuvant radiation therapy depending on nodal state.Consent
Written informed consent was obtained from the patient
for publication of this case and for the accompanying
images.
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